A single center, ambispective,non comparative, observational study evaluating clinical outcomes of Vivity & Vivity Toric IOL up to 3 months of follow-up after bilateral implantation in anIndian population

Medanta Institute of Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Adult subjects 18 years or older with age related cataract with NS grade I to IV on the LOCS III.
•Subject is willing and able to provide informed consent personally or by legal representative.
•Subject follow-up is expected to be possible during the study.
•Bilateral implant of either ACRYSOF Vivity or ACRYSOF Vivity Toric.
•Documented medical history and required preoperative baseline information available for retrospective data collection.

•Patients with any pre-existing ocular co-morbidities/prior refractive surgery would be excluded.
•Patients undergoing corneal refractive surgery post Vivity IOL implantation,
•Patients with manifest refraction(Spherical Equivalent) >0.75 D post-operatively and
•Patients with pregnancy at the time of enrolment would also be excluded.

发起方

Medanta Institute of Education and Research